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Reward Sensitivity Predicts Dopaminergic Response in Spatial Neglect 
 
Abstract 
It has recently been revealed that spatial neglect can be modulated by motivational factors 
including anticipated monetary reward. A number of dopaminergic agents have been 
evaluated as treatments for neglect, but the results have been mixed, with no clear 
anatomical or cognitive predictors of dopaminergic responsiveness. Given that the effects of 
incentive motivation are mediated by dopaminergic pathways that are variably damaged in 
stroke, we tested the hypothesis that the modulatory influences of reward and dopaminergic 
drugs on neglect are themselves related. 
 
We employed a single-dose, double-blind, crossover design to compare the effects of Co-
careldopa and placebo on a modified visual cancellation task in patients with neglect 
secondary to right hemisphere stroke. Whilst confirming that reward improved visual search 
in this group, we show that dopaminergic stimulation only enhances visual search in the 
absence of reward. When patients were divided into REWARD-RESPONDERs and 
REWARD-NON-RESPONDERs, we found an interaction, such that only REWARD-NON-
RESPONDERs showed a positive response to reward after receiving Co-careldopa, whereas 
REWARD-RESPONDERs were not influenced by drug. At a neuroanatomical level, 
responsiveness to incentive motivation was most associated with intact dorsal striatum.  
 
These findings suggest that dopaminergic modulation of neglect follows an ‘inverted U’ 
function, is dependent on integrity of the reward system, and can be measured as a 
behavioural response to anticipated reward. 
 
Keywords: Attention, Motivation, Neglect, Reward, Dopamine 
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Introduction 
Investigators have employed a number of approaches, including drug treatments and non-
invasive brain stimulation, in order to improve symptoms in patients with spatial neglect 
(Cappa, Sterzi, Vallar, & Bisiach, 1987; Koch et al., 2012; O'Shea et al., 2017; Pizzamiglio et 
al., 2004; Rossetti et al., 1998). Although some of these treatments, particularly prism 
adaptation, have shown remarkable results, clinical trials have tended to only demonstrate 
improvement in a subset of patients (Bowen, Hazelton, Pollock, & Lincoln, 2013; Pierce & 
Buxbaum, 2002; van der Kemp, Dorresteijn, Ten Brink, Nijboer, & Visser-Meily, 2017). This 
particularly applies to pharmacological treatments. Noradrenergic and cholinergic agonists 
have been shown to have positive effects on attention in neglect (Dalmaijer et al., 2018; 
Lucas, Saj, et al., 2013), but the majority of drug studies have assessed the effects of 
dopaminergic agents. The dopaminergic system has been of particular interest to 
investigators because damage to dopaminergic tracts has been shown to cause neglect-like 
behaviour in animals, and dopamine receptor stimulation has decreased or ameliorated this 
behaviour (Corwin et al., 1986; Marshall & Gotthelf, 1979). The majority of clinical reports 
have demonstrated a broadly positive effect (Fleet, Valenstein, Watson, & Heilman, 1987; 
Geminiani, Bottini, & Sterzi, 1998; Gorgoraptis et al., 2012; Hurford, Stringer, & Jann, 1998; 
Mukand et al., 2001), although two studies have shown a worsening of neglect with a single 
dose of a dopamine agonist (Barrett, Crucian, Schwartz, & Heilman, 1999; Grujic et al., 
1998). Although investigators have examined whether dopamine might boost performance in 
a specific cognitive domain that is affected in neglect, such as working memory or selective 
attention, no reliable effects in these aspects of cognition have been found in the most 
extensive study to-date (Gorgoraptis et al., 2012). It has been suggested that only neglect 
patients with a specific pattern of neuroanatomical damage would be likely to respond to 
dopaminergic stimulation e.g., that patients with more anterior damage would be least likely 
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to improve. However, neuroanatomical analysis of dopamine responsiveness in neglect has 
not yet shown any systematic pattern (Gorgoraptis et al., 2012). 
 
Following on from Mesulam’s initial anecdotal observation (Mesulam, 1985) of a motivational 
component to neglect, investigators have recently taken an empirical approach to 
understanding how motivation, particularly anticipated monetary reward, influences the 
clinical syndrome of neglect (Lecce et al., 2015; Li et al., 2016; Lucas, Schwartz, et al., 2013; 
Olgiati, Russell, Soto, & Malhotra, 2016; Robertson, 2012). Using a modified standard clinical 
task, we have shown that neglect is improved by anticipated reward in patients without 
damage to the dorsal striatum (Malhotra, Soto, Li, & Russell, 2013), a key node in 
dopaminergic reward-processing circuits (Schultz, 1998). This is in keeping with reports of 
blunted motivational response in patients with clinical apathy secondary to basal ganglia 
dysfunction following stroke, and also in Parkinson’s Disease (PD) (Rochat et al., 2013; 
Schmidt et al., 2008; Shore, Rafal, & Parkinson, 2011). Moreover, in a single case report, 
Adam and colleagues explored the effect of dopaminergic treatment upon reward-response 
and apathy secondary to bilateral basal ganglia stroke. They found that both apathy and 
reward responsiveness improved with dopaminergic stimulation, and that this effect ceased 
upon treatment withdrawal (Adam et al., 2013), mirroring effects observed in PD (Czernecki 
et al., 2002; Muhammed et al., 2016). 
 
This evidence suggests an interplay between reward responsiveness and the effects of 
dopaminergic stimulation, with a possible further link with clinical apathy. Here, we explored 
whether reward responsiveness and basal ganglia damage play a role in the differential 
response to dopaminergic stimulation observed in neglect. Specifically, we did this by 
investigating the effects of dopaminergic stimulation upon response to incentive motivation in 
a group of patients with left neglect following right hemisphere stroke. In this proof-of-concept 
study, we employed a randomised, double-blind, single-dose crossover design comparing 
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the effects of a single dose of L-Dopa (Co-careldopa) with placebo on the modified standard 
cancellation task with which we previously demonstrated the effects of anticipated reward on 
neglect (Malhotra et al., 2013). 
 
Given dopamine’s recognised role in reward processing and the variable effects of 
dopaminergic stimulation in neglect, we hypothesised that response to dopaminergic 
treatment is linked with sensitivity to incentive motivation in each individual patient, which in 
turn is dependent on damage to reward-processing circuitry.  
 
In order to address this hypothesis, we aimed to answer the following three questions: 
i) Does dopamine induce a reward effect in those individuals with neglect who previously 
did not manifest such a motivational response? 
ii) In those who do exhibit a reward-attention interaction (i.e. improvement of neglect with 
anticipated monetary reward) without any pharmacological intervention, what effect does 
subsequent dopaminergic stimulation have on this motivational response? 
iii) Are there any anatomical differences between neglect patients with and without a reward-
attention interaction? Specifically, does damage to the striatum reliably predict a lack of 
response to reward? 
 
In addition, given the demonstrated association between reward responsiveness and 
apathy, we also explored whether individuals with blunted reward-attention responses 
were more likely to have clinical apathy. 
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Methods 
Patients 
Individuals with neglect secondary to first right hemisphere stroke were identified after 
presenting to the stroke unit at Imperial College Healthcare NHS Trust. Neglect was 
operationally defined as omitting more than five targets on the Mesulam shape or 
Behavioural Inattention Test (BIT star cancellation tasks (Mesulam, 1985; Wilson, Cockburn, 
& Halligan, 1987), administered on A3 sheets and timed over two minutes (following 
evidence that healthy individuals under the age of 65 years can complete the shape 
cancellation task in less than two minutes (Weintraub & Mesulam, 1988)). 
 
The following exclusion criteria were applied: age <18 years; significant sensory and/or motor 
impairments affecting patients’ ability to perform the tests; pre-existing neurological 
conditions (for example dementia) that would confound cognitive assessments; acute 
concomitant illness (including cardiac, renal or liver failure); symptomatic postural 
hypotension; history of psychosis or Parkinson’s Disease; antihypertensive medications 
commenced within the previous two weeks; current exposure to monoamine oxidase 
inhibitor, dopaminergic or sympathomimetic drugs; stroke within the previous four weeks; 
pregnancy; breastfeeding. 
 
Eighteen potentially eligible patients with clinical manifestations of neglect were screened 
and took part in the study, with nine individuals excluded from further analysis after 
performing at ceiling on the reward cancellation task in the baseline session (see below and 
Figure 1). Patient demographics are shown in Table 1. All patients provided written informed 
consent before participating in the study, which was approved by the UK National Research 
Ethics Service.  
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Study Design 
A randomised, double-blind, placebo-controlled study design was employed, consisting of 
five separate sessions (baseline, 1a, 1b, 2a, 2b) across three days (Figure 1). 
 
In each session, patients performed a cancellation task with separate Reward and No-reward 
conditions (Malhotra et al., 2013). In the Reward condition, patients had to find and mark 
‘pound coin’ targets amongst featureless distractor stimuli (controlled for hue and luminance) 
on an A3 sheet of paper, whereas in the No-reward condition target stimuli consisted of 
brass button targets with appropriate featureless distractors (Figure 2). Before testing, 
participants were informed that they would receive a monetary reward corresponding to their 
performance on the Reward condition, and performance on the No-reward condition would 
not be related to any subsequent reward (The inclusion of the No-reward control allowed for 
any spontaneous fluctuation in neglect severity). Subjects were asked to circle as many 
targets as they could find and to inform the examiner when they felt that they had completed 
the task. A maximum time period of five minutes was allowed per array.  
 
An apathy assessment was undertaken using the apathy evaluation scale (AES) (Marin, 
Biedrzycki, & Firinciogullari, 1991). Both the clinician (C) and self-rated (S) versions were 
administered, and, where possible, the informant (I) version. To determine the motivational 
characteristics of each individual, the behavioural inhibition/approach system (BIS/BAS) 
questionnaire of Carver and White (1994) was completed. 
 
Day 1 took place within a week of the baseline session, and was divided into two parts, (a) 
and (b), with Session 1b taking place 60 minutes (the time taken for levodopa to reach peak 
plasma concentration) after the end of Session 1a. Patients performed both Reward and No-
reward conditions of the cancellation task in each of these. 
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Either a single oral dose of Co-careldopa 25/100 or placebo was administered to patients at 
the end of Session 1a. We used Co-careldopa because such a combination of L-Dopa and a 
peripheral dopa-decarboxylase inhibitor is the most direct method of dopaminergic 
stimulation (Chong & Husain, 2016). Furthermore, L-Dopa’s lack of specificity for any 
particular dopamine receptor subsets makes it the ideal candidate to exert dopaminergic 
effects on neglect, reward response, and apathy, without the potentially more selective 
effects of a receptor-specific agonist. To counteract the possible side effects of nausea and 
vomiting, oral Domperidone 20 mg was given at the very beginning of session 1 and 2. 
 
Day 2 took place within a week of Day 1, but those who received L-Dopa previously were 
given placebo on this occasion and vice versa. Randomisation was carried out by the 
pharmacy at Imperial College Healthcare NHS Trust, and both examiners and patients were 
blind to whether Co-careldopa or placebo was being administered. Within and between 
individuals, the order in which the Reward and No-reward conditions were performed was 
counterbalanced between the baseline and other sessions. 
 
To limit practice effects, five different variations (each with equal numbers of targets and 
distractors, but with jittered spatial positions) of each cancellation array were used, one for 
each of the five sessions, with the configuration of the Reward and equivalent No-reward 
conditions being the same in each session. The order in which the five arrays were 
administered across sessions was counterbalanced across patients. 
  
After completion of both cancellation conditions in each session, subjects were asked to rate 
their motivational levels for each on a simple visual analogue scale (VAS) composed of a 
100 mm length horizontal black line. They were instructed to place a single vertical mark 
across the scale at a point which they felt best represented their motivational levels on the 
No-reward condition in black and on the Reward condition in red, with the left and right 
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extremities of the line representing minimum and maximum levels respectively. It should be 
noted that this scale was being used to test for a difference between subjective motivation 
levels for the two conditions within individuals, which should not be affected by any rightward 
bias. Patients received vouchers after completion of both tasks in each session in 
accordance with their performance, up to a maximum of £10. As requested by the Ethics 
committee all patients received an equal sum (total worth £50) by completion of the study.  
 
Analysis 
In our previous study, we found an effect of reward on cancellation task performance in the 
second session, after participants had received reward, and consistent with the results of 
experiments in healthy individuals (Anderson, Laurent, & Yantis, 2011; Bourgeois, Neveu, 
Bayle, & Vuilleumier, 2017; Della Libera & Chelazzi, 2006; Kiss, Driver, & Eimer, 2009). In 
order to examine the effects of reward and consequently the effects of L-Dopa on such a 
reward-attention interaction in this study, those subjects who performed at or above ceiling 
(defined as finding >50 targets) on the reward task in the baseline session were excluded 
from further analysis. To determine whether or not the effects of L-Dopa differ in the 
presence or absence of a reward response, we made an a priori decision to divide the 
remaining subjects into REWARD-RESPONDER and REWARD-NON-RESPONDER groups 
on the basis of their performance in Session 1a. This subdivision was not affected by the 
order of presentation of each condition in Session 1a. As in our previous study (Malhotra et 
al., 2013), the former were defined as those who found more targets in the Reward condition 
compared to the No-reward condition in Session 1a (and before receiving any medication).  
 
Lesion Anatomy 
Using the MRIcron software package (www.mccauslandcenter.sc.edu/mricro/mricron), each 
patient’s stroke lesion was manually mapped directly by a trained neurologist onto their 
native clinical CT or MRI (DWI or FLAIR if the images were, respectively, acquired within or 
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beyond 48 hours of stroke onset), on all axial slices where lesion was evident. The 
anatomical scan and lesions were subsequently mapped onto stereotaxic space using 
Clinical Toolbox for spatial normalisation (www.mccauslandcenter.sc.edu/CRNL/clinical-
toolbox), implemented via the SPM8 software package 
(www.fil.ion.ucl.ac.uk/spm/software/spm8). 
 
We determined, for each patient, relative lesion volume overlapping regions of interest 
across the whole brain. These were obtained from reference atlases of Brodmann Areas, 
cortical and subcortical structures, and white matter tracts (Desikan et al., 2006; Zhang et al., 
2010). The proportion of each ROI occupied by lesion was calculated for each subject by 
matrix multiplication, i.e.: lesion profile (row vector) x ROI (column vector) (Rinne et al., 
2013). Such a region-of-interest approach to test anatomical associations respects the fact 
that cognitive functions are spatially distributed (Gajardo-Vidal et al., 2018). Subject-level 
values were compared between groups using univariate logistic regression. All analyses 
were performed in MATLAB (The Mathworks, inc.) with a statistical threshold of p<0.05 set 
for each. 
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Results 
 
There were no adverse events or side effects reported by any of the participants during the 
study. Repeated-measures ANOVA was the parametric statistical analysis of choice. Input 
factors were condition (referring to the two levels of No-reward and Reward), drug (referring 
to the two testing days on which either placebo or L-Dopa was given) and session (referring 
to the pre-drug (a) and post-drug (b) sessions, regardless of placebo or L-Dopa), with reward 
response (REWARD-RESPONDERs versus REWARD-NON-RESPONDERs) as a between-
subjects factor. The assumption of homogeneity of variance was tested using Levene’s test 
of equality of variances.  
 
Total Cancellation Performance 
The data for total number of targets found were not normally distributed, as measured using 
the Kolmogorov-Smirnov test, and were thus reverse-scored followed by a log transformation 
in order to correct unequal variances. Using the transformed data across all 9 patients, a 
three-factorial (condition x drug x session) repeated measures ANOVA revealed a main 
effect of condition (F(1,8)=7.89, p=0.023, = 0.50), with a greater number of targets found in 
the Reward condition (mean 37.7, SEM 5.3) than in the No-reward condition (mean 35.3, 
SEM 4.8) (Figure 3A). There was no significant correlation between reward response and 
baseline cancellation task (Mesulam shape or BIT star task) performance suggesting that 
there was no relationship between neglect severity and reward responsivity. 
 
There was no main effect of L-Dopa on cancellation performance, but there was a 3-way 
interaction (F(1,8)=5.13, p=0.05, = 0.39). Planned contrasts showed that the interaction was 
due to a condition x drug interaction specifically on post-drug (b) sessions (F(1,8)=7.73, 
p=0.024), = 0.49), with significantly more targets found in the No-reward condition 
following L-Dopa (mean 37.9, SEM 5.6) compared to following placebo (mean 32.7, SEM 
2
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4.5) (t(8)=2.45, p=0.04), suggesting that L-Dopa modulated neglect in the absence of reward 
(Figure 3B). By contrast, there was no difference in performance post-placebo versus post-L-
Dopa for the Reward condition (t(8)=0.61, p=0.56). Therefore L-Dopa did not have a 
synergistic effect with reward. There were no other main effects or interactions (all p values > 
0.08).  
 
Cancellation in each Hemispace 
A four-factorial (condition x drug x session x hemispace) repeated measures ANOVA for the 
number of targets found on each side of the cancellation array revealed a main effect of 
hemispace, (F(1,8)=11.42, p=0.010, = 0.59), with fewer targets found on the left (mean 
14.5, SEM 3.2) than on the right (mean 21.9, SEM 2.1). However, there was no condition x 
hemispace interaction (F(1,8)=1.15, p=0.316). That is, incentive motivation improved 
performance across the visual space but not specifically in neglected hemispace. Moreover, 
there was no condition x drug x session x hemispace interaction, (F(1,8)=0.35, p=0.57). That 
is, the modulating effects of L-Dopa occurred across visual space and not specifically in 
neglected hemispace. 
 
REWARD-RESPONDERs versus REWARD NON-RESPONDERs 
In a mixed-design ANOVA (condition x drug x session with reward response as a between-
subjects factor) examining the number of targets found, a condition x session x reward 
response interaction (F(1,7)=7.33, p<0.05) was present. In post hoc analyses, a condition x 
reward response interaction in the pre-drug sessions approaching significance was identified 
(F(1,7)=5.12, p=0.058, = 0.42). That is, as would be expected from their performance in 
Session 1a, in all pre-drug sessions REWARD-RESPONDER patients performed better in 
the Reward (mean number of targets found 39.6, SEM 6.9) compared to the No-reward 
(mean number of targets found 35.0, SEM 6.6) condition, whereas REWARD-NON-
2
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RESPONDERs performed worse in the Reward (mean number of targets found 30.5, SEM 
7.8) condition compared to the No-reward (mean number of targets found 35.8, SEM 7.4) 
condition. 
 
A significant session x reward response interaction for the reward condition (F(1,7)=5.46, 
p=0.05, = 0.44) was also present. During the Reward condition, the performance of 
REWARD-RESPONDERs was better in the pre-drug sessions (as expected) compared to 
REWARD-NON-RESPONDERSs but not different in post-drug sessions, with the 
performance of REWARD-NON-RESPONDERs improving from pre- (mean number of 
targets found 30.5, SEM 7.8) to post- (mean number of targets found 39.3, SEM 9.0) drug 
sessions. 
 
There was also a near-significant drug x session x reward response three-way interaction 
(F(1,7)=5.27, p=0.055, = 0.43). Post hoc tests performed to determine the source(s) of this 
interaction suggested that it could be accounted for by a session x reward response 
interaction for the L-Dopa treatment day (F(1,7)=8.91, p=0.02, = 0.56) (Figure 3C). That is 
REWARD-RESPONDER performance was worse following L-Dopa whereas REWARD-
NON-RESPONDERs performed better, specifically on the Reward task (t(3)=3.04, p=0.056).  
 
A further five-factorial (condition x drug x session x hemispace x reward-response) ANOVA 
for the number of targets found in each hemispace revealed main effects of condition, 
session and hemispace but no interaction involving hemispace and reward-response.  
 
Subjective Motivation and Apathy 
2
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Using a repeated measures ANOVA, we examined subjective motivation in the pre-placebo 
combined with pre-L-Dopa conditions only (to exclude any potential drug effects). Condition x 
reward-response repeated measures ANOVA revealed a main effect of reward (F(1,7)=11.01, 
p=0.013, = 0.61), with mean VAS scores for Reward (mean 79.65, SEM 5.76) being 
higher than mean VAS scores for No-reward (mean 57.63, SEM 7.67). There was no 
condition x reward-response interaction (F(1,7)=0.16, p=0.70, = 0.023). There was no 
significant difference between REWARD-RESPONDERs and REWARD-NON-
RESPONDERs (F(1,7)=0.86, p=0.39, = 0.11). Non-parametric analysis (data for the reward 
post-L-Dopa session were not normally distributed) of all VAS scores (See Table 2) using 
Mann-Whitney U tests showed no differences between the VAS scores of the REWARD-
RESPONDER and REWARD-NON-RESPONDER groups, for each of Reward and No-
reward conditions for each of the pre-placebo, post-placebo, pre-L-Dopa and post-L-Dopa 
sessions. Both REWARD-RESPONDERs and REWARD-NON-RESPONDERs subjectively 
rated their motivational levels as being higher when performing the Reward condition 
compared to the No-reward condition. 
 
The scores from each of the C, S and I versions of the AES were compared with paired 
samples t-tests (2 patients did not have informant AES). The clinician AES was significantly 
greater than the self-rated AES (C mean = 39.3, S mean = 33.0, t(8)=2.64, p=0.03), and there 
was a near-significant difference between the informant AES and the self-rated AES (I mean 
= 42.0, S mean = 34.7, t(6)=2.43, p=0.051). There was no difference between the clinician 
and informant AES (C mean = 38.6, I mean = 42.0, t(6)=-1.01, p=0.35). The scores for the 
reward responsiveness subscale of the BAS scale (BAS-RR) negatively correlated 
(Pearson’s correlation) with the self-rated apathy scores (r(9)=-0.958, p<0.005) but not with 
clinician or informant scores. However, an independent samples t-test comparing REWARD-
RESPONDER with REWARD-NON-RESPONDER patients revealed no significant 
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differences between the groups for any of the apathy scores (clinician (t(7)=0.735, p=0.49), 
informant (t(5)=0.507, p=0.63) or self-rated (t(7)=0.745, p=0.48)) or the mean BAS-RR scores 
(t(7)=0.86, p=0.42). 
 
Lesion Anatomy 
Figure 4 shows the lesion overlap images for the 4 REWARD-RESPONDER patients (panel 
A) and 5 REWARD-NON-RESPONDERs patients (panel B), with lesion subtraction 
(REWARD-NON-RESPONDERs minus REWARD-RESPONDERs) shown in Panel C. We 
assessed whether the striatum was more likely to be damaged in the REWARD-NON-
RESPONDERs than the REWARD-RESPONDERs by examining the proportion of the dorsal 
striatum ROI (R ant. caudate + R ant. putamen) that was damaged in each group. This 
showed that voxels in the dorsal striatum ROI were more likely to be damaged in REWARD-
NON-RESPONDERs than in REWARD-RESPONDERs (t=2.43, p=0.046). Exploratory 
analysis across all other brain regions showed that no other ROIs were significantly more 
affected in the REWARD-NON-RESPONDERs than in the REWARD-RESPONDER group 
(threshold of p<0.05 uncorrected). 
 
Discussion 
In this randomised, double-blind, placebo-controlled proof-of-concept study, we investigated 
the interaction between dopaminergic sensitivity and response to incentive motivation in 
spatial neglect. 
 
Reward Effects on Cancellation Task Performance 
The presence of monetary incentive improved neglect as measured by overall performance 
on a cancellation task, which is consistent with previous findings and in line with the 
motivational effects of monetary reward on spatial attention reported in healthy adults 
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(Anderson et al., 2011; Bagurdes, Mesulam, Gitelman, Weintraub, & Small, 2008; Della 
Libera & Chelazzi, 2006; Kiss et al., 2009; Lucas, Schwartz, et al., 2013; Malhotra et al., 
2013; Small et al., 2005). Consistent with this, patients felt subjectively more motivated, as 
evidenced by the overall higher ratings on the VAS for the rewarded task. 
 
Effect of Levodopa on Cancellation Performance 
In the current study there was no overall effect of dopamine on cancellation performance at a 
group level. This is in contrast to other studies showing an improvement in neglect with 
dopamine agonists or Levodopa. The majority of reports have demonstrated a broadly 
positive effect (Fleet et al., 1987; Geminiani et al., 1998; Gorgoraptis et al., 2012; Hurford et 
al., 1998; Mukand et al., 2001), although two studies have shown a worsening of neglect with 
a single dose of a dopamine agonist (Barrett et al., 1999; Grujic et al., 1998). However, it 
should be noted that the first of these was a single-case study in an individual with motor-
intentional neglect. It has been suggested that only neglect patients with a specific pattern of 
neuroanatomical damage would be likely to respond to dopaminergic stimulation e.g., that 
patients with more extensive frontal damage would be least likely to improve. However, 
neuroanatomical analysis of dopamine responsiveness in neglect has not yet shown any 
systematic pattern (Gorgoraptis et al., 2012), although to our knowledge, no authors have yet 
examined whether striatal damage influences dopaminergic response. The current study was 
designed in order to examine whether such differential responses might be explained, at 
least to some extent, by the influence of motivational deficits and damage to reward circuitry. 
Therefore, we systematically assessed the interaction between levodopa treatment and 
reward responsiveness. 
 
Interaction of Reward Response with Reward and Levodopa Effects on Cancellation 
Task Performance 
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Across the whole patient group, there was no evidence for a synergistic effect of exogeneous 
dopamine administration with reward. It is possible that dopamine does not differentially 
influence performance on the two experimental task variants, but this is not supported by its 
distinct effects in REWARD-RESPONDERs and REWARD-NON-RESPONDERS (Figure 
3C). Instead  we would suggest that our results may be accounted for by inverted U-shape 
function associated with dopaminergic effects on cognitive performance (Cools & D'Esposito, 
2011). That is, optimal levels of brain dopamine are required to drive the modulation of 
neglect, but suboptimal or supraoptimal levels are likely to impair them (Figure 5). This is 
consistent with observed performance in the No-reward condition, where there was a 
suggestion that at a group level, L-dopa improved cancellation task performance compared 
to placebo. 
 
Critically, this account is in keeping with the differential effects of L-Dopa in REWARD-
RESPONDERs versus REWARD-NON-RESPONDERs. The REWARD-RESPONDER  
group demonstrated no additional benefit of L-Dopa, but rather performance tended to 
deteriorate on the Reward task following a single L-Dopa dose. This finding would again 
support the inverted U-shape relationship as discussed above. It has been shown that 
incentive motivation leads to increased endogeneous dopaminergic activity (Wassum, 
Ostlund, Loewinger, & Maidment, 2013), and it is therefore possible that the administration of 
exogenous dopamine could lead to excessive dopamine levels in the REWARD- 
RESPONDER group when performing the pound coin condition after receiving L-Dopa.  The 
tendency to worse performance on this condition also provides evidence against a ceiling 
effect preventing a synergistic response to reward and dopamine in this group. Moreover, it 
is consistent with an inverted U-shape function relating dopamine levels to cognitive 
performance (Cools & D'Esposito, 2011). . The REWARD-NON-RESPONDER group,  
having previously showed no reward-attention interaction, demonstrated an overall 
improvement in performance on the Reward task following L-Dopa. This suggests that L-
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Dopa ‘induces’ a reward-attention interaction in the REWARD-NON-RESPONDER group, 
and is in keeping with the single-case study carried out by Adam and colleagues (2013). It is 
also consistent with Parkinson’s Disease research where blunted reward processing in 
patients off medications was enhanced following dopamine agonist administration (Bodi et 
al., 2009). This induction of a reward-attention interaction might be explained by a variation in 
optimal levels of dopamine between the REWARD-RESPONDER and REWARD-NON-
RESPONDER groups secondary to lesion anatomy (see below). 
 
Anatomy of Reward-Responsiveness and the Interaction between Motivational and 
Attentional Networks 
The patient group had a wide range of lesions as previously described in the neglect 
literature (Lunven et al., 2015; Ramsey et al., 2016). However, as can be seen in Figure 4, 
and as per our ROI analysis, the REWARD-NON-RESPONDER group was more likely to 
have damage to the dorsal striatum (DS). This result was obtained with a relatively lenient 
threshold, and should be interpreted with some caution, but it is in keeping with prior studies, 
including our own (Malhotra et al., 2013). Below we offer an account that integrates the 
lesion findings in this context. While the DS is primarily associated with action selection and 
movement, there is considerable evidence for its role in motivational processing. For 
example PET studies have reported an increase in dopamine release in both DS and ventral 
striatum when participants played a video game for anticipated monetary incentives, similar 
to our paradigm (Koepp et al., 1998), and in DS when healthy humans performed card 
selection tasks for monetary gain (Zald et al., 2004). Similarly, fMRI studies have reported 
increases in blood oxygenation level dependent responses in DS in anticipation of monetary 
reward (Knutson, Adams, Fong, & Hommer, 2001). Interestingly, there was no difference 
between groups in VAS score, with both groups rating their motivation to be higher for the 
Reward versus the No-reward condition. Thus, damage to DS in this and our previous study 
appeared to disrupt the behavioural sequelae of incentive motivation, even though 
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REWARD-NON-RESPONDERs reported greater motivation for the Reward condition. This is 
in keeping with findings from healthy humans showing that the striatum is a key structure 
linking motivation to action (Harsay et al., 2011). 
 
The observation that the REWARD-NON-RESPONDERs were more likely to have damage 
to the right dorsal striatum is also consistent with animal studies demonstrating that neglect-
like behaviour caused by cortical lesions is induced or worsened by additional striatal 
damage (Carli, Jones, & Robbins, 1989; Christakou, Robbins, & Everitt, 2005; Van Vleet, 
Heldt, Pyter, Corwin, & Reep, 2003), and it should be noted that the majority of animal 
experiments evaluating attention explicitly probe reward-seeking behaviour. Moreover, such 
neglect-like symptoms in animals can be modulated by dopaminergic stimulation (van Vleet, 
Heldt, Corwin, & Reep, 2003). Neuroanatomical studies of clinical neglect have 
understandably tended to focus on frontoparietal networks involved in spatial and non-spatial 
aspects of attention, but it is important to consider how the syndrome might result from 
interactions between component deficits (Rafal, 1994). Although some studies have 
investigated neglect solely secondary to basal ganglia damage, there have been very few 
clinical studies exploring the effects of damage to reward-related striatal systems in 
combination with fronto-parietal network disruption, even though this is likely to result in 
altered interactions between motivational and attentional systems (Bourgeois, Chelazzi, & 
Vuilleumier, 2016). 
 
Our findings do not rule out the possibility that the effects of both reward and L-dopa are 
mediated by an increase in arousal. In fact, we have previously found that incentive 
motivation does appear to affect arousal on a trial-by-trial basis (Olgiati et al., 2016). In 
addition, the apparent absence of hemispace-specific responses to reward and dopaminergic 
stimulation, implies that they both might act via a non-lateralised attentional mechanism. 
However, the authors of two previous studies have concluded that the positive effects of 
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dopaminergic stimulation in neglect are unlikely to be mediated by arousal (Geminiani et al., 
1998; Gorgoraptis et al., 2012). Perhaps crucially, L-dopa, which has clearly been shown to 
modulate arousal in Parkinson’s Disease (Horvath & Meares, 1974), was not the compound 
used in those studies. When L-dopa has been found to improve neglect, a boost in arousal 
has been suggested as a possible mechanism of action (Mukand et al., 2001). 
 
Relationship of Apathy to Reward Response 
The presence of apathy has recently been associated with reward insensitivity in patients 
with ischaemic brain damage (Adam et al., 2013; Rochat et al., 2013; Schmidt et al., 2008). 
In our study, the self-reported apathy scores of patients showed a strong negative correlation 
with their scores on the reward responsiveness subscale of the BAS scale, with the more 
apathetic patients being less responsive to reward on this questionnaire. This is likely to 
relate to both these scales being self-rated, and the relative similarity of questions in each. In 
contrast, clinician and informant scores did not correlate with the BAS-RR scale, suggesting 
that there was not a clear relationship between apathy and reward responsiveness in this 
group. Moreover, there was no significant difference in any of the apathy scores between the 
REWARD-RESPONDER and REWARD-NON-RESPONDER groups. It is possible that the 
reported differences between apathy and behavioural reward responsiveness may reflect 
differences in how apathy has been defined across other studies. Whereas Adam et al. 
(2013) and Rochat and colleagues (Rochat et al., 2013) measured apathy using the Apathy 
Inventory, the present study utilised instead the AES, the latter considered to be one of the 
most psychometrically robust broad measures of apathy (Clarke et al., 2011). The absence 
of a relationship between apathy and lack of reward response as seen in the current study is 
consistent with the results of Chong and colleagues (Chong et al., 2015), who demonstrated 
that even in the absence of apathy, PD patients showed deficits in reward-incentivised 
decision-making.  
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Dopaminergic Treatment in Stroke 
In addition to being used in trials attempting to improve neglect, it has been suggested that 
dopaminergic stimulation may improve other post-stroke cognitive deficits such as aphasia, 
or augment stroke rehabilitation as a whole (Bhakta et al., 2014; Gill & Leff, 2012). However, 
to-date there have been no universally successful trials of dopaminergic stimulation in stroke 
rehabilitation, and the results of the current study suggest that assessing motivational 
responsiveness may be helpful in determining which individuals will respond to L-dopa or 
dopamine agonists.  As discussed above, apathy has been shown by some groups to relate 
to reward responsiveness, and has been shown to improve with dopaminergic stimulation 
(Adam et al., 2013; Kohno et al., 2010). It might be that subgroup analysis assessing apathy 
status could help identify those patients who are more likely to respond. However, we note 
that in our group of patients, apathy did not directly map into blunted reward response, and 
apathy scales may not be as sensitive as the direct assessment of reward sensitivity.  
 
Conclusions 
The current study demonstrates that there is an interaction between dopamine 
responsiveness and sensitivity to incentive motivation in patients with spatial neglect, which 
may be mediated by striatal damage. Reward improved performance across the patient 
group, and a single dose of L-dopa only improved reward-related performance in those 
individuals who did not previously respond to reward. These results are consistent with the 
proposal that the relationship between dopamine and neglect is dose-dependent, and 
dictated by an inverted U-shape function. These results demonstrate the importance of the 
interactions between motivational and attentional deficits for our understanding of 
responsiveness to dopaminergic stimulation in neglect, and potentially in the wider field of 
stroke rehabilitation. 
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Patient Sex Age (years) 
Time since Stroke 
(months) 
BIT Star Cancellation Mesulam Shape Cancellation 
L R Total (54) L R Total (60) 
1 M 74 15 0 5 5 0 2 2 
2 M 49 87 0 25 25 0 25 25 
3 M 64 70 21 27 48 17 27 44 
4 M 59 30 20 20 40 17 18 35 
5 M 70 45 23 27 50 22 24 46 
6 M 84 8 8 13 21 5 18 23 
7 M 59 2 3 22 25 0 15 15 
8 F 59 3 0 17 17 0 15 15 
9 M 64 4 0 15 15 0 10 10 
Table 1: Patient Demographics and Performance on Standard Cancellation Tasks 
All patients presented following their first stroke and apart from Patient 8, all had ischaemic strokes. All patients had manifested clinical 
neglect at presentation. BIT Star and Mesulam Shape Cancellation scores indicate number of targets found in each hemifield as well as 
total number of targets found. All patients commenced cancellation on the right side of the array. 
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Patient 
AES Scores BIS/BAS Scores Mean VAS Scores Reward-
Attention 
Response C I S BAS-Drive BAS-Fun BAS-RR BIS NR R 
1 30 34 34 10 10 18 24 62.8 72.8 RNR 
2 24 24 19 13 14 20 23 37.8 69.3 RR 
3 25 43 27 14 10 19 8 35.3 83.5 RNR 
4 49 60 41 14 12 17 23 46.8 97.3 RR 
5 55 49 52 12 9 14 19 90.0 90.0 RR 
6 42 - 28 16 10 20 26 71.0 87.0 RR 
7 39 43 36 11 13 17 26 76.8 75.5 RR 
8 48 41 34 14 14 18 24 26.3 45.8 RNR 
9 42 - 26 15 15 20 23 79.0 100.0 RNR 
Table 2: Apathy and Motivation Scores  
 
C = clinician, I = informant, S = self-rated versions of the AES = apathy evaluation scale; BIS/BAS = behavioural inhibition/approach system; BAS-RR = 
reward responsiveness subscale of the BAS; VAS = visual analogue scale; NR = No-reward condition; R = Reward condition; RR = REWARD-
RESPONDERs; RNR = REWARD-NON-RESPONDERs 
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Figure Legends 
Figure 1  
Study Design 
Schematic showing randomised, single-dose, placebo-controlled crossover study design 
 
Figure 2 
Cancellation task from Malhotra et al. (2013) 
In each array there were 54 targets (27 each side of midline) amongst 52 matched 
distractors; targets and distractors were 12mm in diameter. Distractors were produced for 
each task by using a Gaussian blur to merge the features of each target until they were no 
longer distinguishable but remained identical in overall distribution of hue and luminance (for 
further details see Malhotra et al. (2013)). In order to ensure that participants did not learn 
exactly where targets were on the display from session to session, we employed 5 different 
arrays. Each of these employed the same number of targets and distractors, and the same 
configurations were used for both conditions in each individual session. Condition order was 
counterbalanced within and between individuals. 
 
A: Reward condition 
For the Reward condition, patients were asked to find and mark all the target images of 
pound coins on the A3 sized array, and were informed that they would receive one pound for 
each target that they correctly marked.  
B: No-reward condition 
For the No-reward condition, patients were asked to find and mark all the images of buttons 
on the A3 sheet of paper and were informed that they would not receive any money in 
relation to their performance.  
 
 
Figure 3:  
Effect of Reward and L-Dopa on Cancellation Performance at a Group Level 
A: Overall effect of reward on neglect on cancellation tasks across all sessions  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Log-transformed reverse scores for the total number of targets found. Values closer to 0 = 
greater number of targets found; There was a main effect of condition (F(1,8)=7.89, p<0.05), 
with more targets found in the Reward condition than the No-reward condition Error bars = 
standard error.  
B: Effect of L-Dopa versus placebo on No-Reward and Reward conditions 
Difference between performance post-L-Dopa and performance post-placebo in both 
conditions expressed as a percentage. L-dopa led to a 13% increase in targets found on the 
No-reward task whereas performance on the Reward task worsened by approximately 10% 
after L-dopa when compared to placebo. Error bars = standard error. 
C: Change in task performance with L-Dopa for REWARD-RESPONDERs and 
REWARD-NON-RESPONDERs on both task conditions 
Effect of L-Dopa on performance (post-L-Dopa minus pre-L-Dopa) on the Reward and No-
reward tasks for the two groups. REWARD-NON-RESPONDERs (n=4) improved by 44% 
whereas REWARD-RESPONDERs’ (n=5) performance worsened by 13% on the Reward 
task. The two groups did not show significantly different responses to L-dopa in the No-
reward condition. Error bars = standard error, * p<0.05. 
 
Figure 4: Anatomical differences between REWARD-RESPONDERs & REWARD-NON-
RESPONDERs  
A: Lesion overlap images for 4 REWARD-NON-RESPONDER patients; B: Lesion 
overlap images for 5 REWARD-RESPONDER patients; C: Lesion subtraction showing 
regions damaged in REWARD-NON-RESPONDERs that were less likely to be damaged 
in reward responders. 
Sagittal images show slice levels. For panels A&B, the number of patients with damage to 
each region is represented by the multi-coloured bars, with one patient depicted by the 
leftward-most violet colour, and the maximum number of patients as indicated by red on the 
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far right. In panel C, regions that were damaged in REWARD-NON-RESPONDERs that were 
less likely to be damaged in REWARD-RESPONDERs, represented as a percentage as 
indicated by the legend to the right of the panel. 
 
 
Figure 5: Dose-dependent effects of Dopamine on cancellation task performance 
A: We propose that the relationship between cancellation task performance and dopamine 
levels follows an inverted U-shape function (Cools & D'Esposito, 2011), where both 
insufficient (for example, in the absence of both reward and levodopa) and excessive (for 
example, the administration of levodopa with reward) dopamine levels lead to worse 
performance. NR = No-reward; R = Reward 
 
B: Dose-dependent effects of dopamine on cancellation task performance according 
to reward response 
Optimal levels of dopamine may vary between individuals who demonstrate an initial reward-
attention response (REWARD-RESPONDERs, RRs = red curve) and those who do not 
(REWARD-NON-RESPONDERs, RNRs = green curve), which may, in part, be dictated by 
basal dopamine concentrations. Thus, for the same rise in dopamine level (black arrow), the 
performance of REWARD-NON-RESPONDERs may improve (green curve) whereas that of 
REWARD-RESPONDERs deteriorates (red curve). Furthermore, REWARD-NON-
RESPONDERs may be operating within a wider range, requiring greater concentrations to 
effect a similar change in performance to REWARD-RESPONDERs.  
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